Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Jun;10(6):1102-9.
doi: 10.3201/eid1006.030635.

Antimicrobial resistance among Campylobacter strains, United States, 1997-2001

Amita Gupta  1 , Jennifer M Nelson, Timothy J Barrett, Robert V Tauxe, Shannon P Rossiter, Cindy R Friedman, Kevin W Joyce, Kirk E Smith, Timothy F Jones, Marguerite A Hawkins, Belershacew Shiferaw, James L Beebe, Duc J Vugia, Terry Rabatsky-Ehr, James A Benson, Timothy P Root, Frederick J Angulo; NARMS Working Group
Affiliations
Comparative Study

Antimicrobial resistance among Campylobacter strains, United States, 1997-2001

Amita Gupta et al. Emerg Infect Dis. 2004 Jun.

Abstract

We summarize antimicrobial resistance surveillance data in human and chicken isolates of Campylobacter. Isolates were from a sentinel county study from 1989 through 1990 and from nine state health departments participating in National Antimicrobial Resistance Monitoring System for enteric bacteria (NARMS) from 1997 through 2001. None of the 297 C. jejuni or C. coli isolates tested from 1989 through 1990 was ciprofloxacin-resistant. From 1997 through 2001, a total of 1,553 human Campylobacter isolates were characterized: 1,471 (95%) were C. jejuni, 63 (4%) were C. coli, and 19 (1%) were other Campylobacter species. The prevalence of ciprofloxacin-resistant Campylobacter was 13% (28 of 217) in 1997 and 19% (75 of 384) in 2001; erythromycin resistance was 2% (4 of 217) in 1997 and 2% (8 of 384) in 2001. Ciprofloxacin-resistant Campylobacter was isolated from 10% of 180 chicken products purchased from grocery stores in three states in 1999. Ciprofloxacin resistance has emerged among Campylobacter since 1990 and has increased in prevalence since 1997.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of ciprofloxacin MICs among Campylobacter jejuni isolated from humans and retail chicken. A, human isolates, 1997–2001; N = 1,471. B, grocery store purchased chicken isolates, 1999; N = 62.
Figure 2
Figure 2
Quinolone- and fluoroquinolone-resistant Campylobacter jejuni in the United States, 1982–2001. FQ, fluoroquinolone; MN, Minnesota quinolone resistance among C. jejuni strains data (adapted from 18), NARMS, National Antimicrobial Resistance Monitoring System. Prior survey data adapted from reference and .
See this image and copyright information in PMC

Comment in

References

    1. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, et al. Food-related illness and death in the United States. Emerg Infect Dis. 1999;5:607–25. 10.3201/eid0505.990502 - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention. Preliminary FoodNet data on the incidence of foodborne illnesses—selected sites, United States, 2002. MMWR Morb Mortal Wkly Rep. 2003;52:340–3. - PubMed
    1. Altekruse SF, Stern NJ, Fields PI, Swerdlow DL. Campylobacter jejuni—an emerging foodborne pathogen. Emerg Infect Dis. 1999;5:28–35. 10.3201/eid0501.990104 - DOI - PMC - PubMed
    1. Allos BM. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis. 2001;32:1201–6. 10.1086/319760 - DOI - PubMed
    1. Salazar-Lindo E, Sack RB, Chea-Woo E, Kay BA, Piscoya ZA, Leon-Barua R, et al. Early treatment with erythromycin of Campylobacter jejuni–associated dysentery in children. J Pediatr. 1986;109:355–60. 10.1016/S0022-3476(86)80404-8 - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources